This registry aims to provide insights on the pathogenic mechanisms that expose subjects with CILCA arch to the increased risk of postoperative complications. So, the CILCA arch registry will capture clinical data and medical images of subjects with CILCA arch treated by surgical or endovascular (TEVAR) means. Study Design: International Multicenter and Observational registry Estimated Enrolment: 500 patients, with competitive enrolment. Clinical Follow up: Postoperatively at 30 days, at 12 months, and yearly after.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Angulation of ascending aortic curvature
Timeframe: From Admission to 5 years follow-up
Arch angle
Timeframe: From Admission to 5 years follow-up
Centerline curvature radius (mm)
Timeframe: From Admission to 5 years follow-up
Outer curvature radius (mm)
Timeframe: From Admission to 5 years follow-up
Centerline tortuosity
Timeframe: From Admission to 5 years follow-up
Volume of the ascending aorta (cm3)
Timeframe: From Admission to 5 years follow-up
Massimiliano Maria Marrocco-Trischitta, MD, PhD